Staff Profile

Professor of Neuropathology

Honorary Consultant Pathologist 

Director, Neuropathology Newcastle Brain Tissue Resource

Editor-in-Chief, Acta Neuropathologica

Chair Neuropathology Proceedings Group Brains for Dementia Research

Area of expertise: Neuropathology, Neurodegeneration

Google Scholar: Click here.

Research Interests

My research interest is neurodegenerative diseases of the ageing brain with a focus on clinico-neuropathological correlative studies. Despite the categorisation of age associated neurodegenerative diseases into specific subtypes, such as Alzheimer's disease and Lewy body diseases, it becomes more and more apparent that the ageing brain is characterised by the presence of multiple pathologies. Hence, I aim to improve the neuropathological assessment of this cerebral multimorbidity (e.g. by employing fully automated quantitative assessment of neuropathological lesions) to evaluate the combined influence of various morbidities on the clinical picture as this might lead to the identification of new disease subtypes and thereby to the development of novel therapeutic strategies against age associated neurodegeneration.

167 publications since 2003, times cited: 4583, h-index: 40 (google scholar, Jan 2017)

See also the website of my research group: http://research.ncl.ac.uk/ndprg/

• Articles

  • Walker L, Simpson H, Thomas AJ, Attems J. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer’s disease. Acta Neuropathologica Communications 2024, 12(1), 28.
  • Hamilton CA, Matthews FE, Attems J, Donaghy PC, Erskine D, Taylor J-P, Thomas AJ. Associations between multimorbidity and neuropathology in dementia: Consideration of functional cognitive disorders, psychiatric illness and dementia mimics. British Journal of Psychiatry 2024, epub ahead of print.
  • Nelson PT, Lee EB, Cykowski MD, Alafuzoff I, Arfanakis K, Attems J, Brayne C, Corrada MM, Dugger BN, Flanagan ME, Ghetti B, Grinberg LT, Grossman M, Grothe MJ, Halliday GM, Hasegawa M, Hokkanen SRK, Hunter S, Jellinger K, Kawas CH, Keene CD, Kouri N, Kovacs GG, Leverenz JB, Latimer CS, Mackenzie IR, Mao Q, McAleese KE, Merrick R, Montine TJ, Murray ME, Myllykangas L, Nag S, Neltner JH, Newell KL, Rissman RA, Saito Y, Sajjadi SA, Schwetye KE, Teich AF, Thal DR, Tome SO, Troncoso JC, Wang S-HJ, White CL, Wisniewski T, Yang H-S, Schneider JA, Dickson DW, Neumann M. LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathologica 2023, 145, 159–173.
  • Pifl C, Reither H, Attems J, Zecca L. Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson. npj Parkinson's Disease 2023, 9(1), 89.
  • Katanga JA, Hamilton CA, Walker L, Attems J, Thomas AJ. Age-related hearing loss and dementia-related neuropathology: An analysis of the United Kingdom brains for dementia research cohort. Brain Pathology 2023, 33(6), e13188.
  • Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, Abdi IY, Poggiolini I, Santos P, Dorn A, Carloni P, Vekrellis K, Attems J, McKeith I, Outeiro TF, JEnsen PH, El-Agnaf OMA. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proceedings of the National Academy of Sciences 2022, 119(15), e2109617119.
  • Hatton C, Ghanem SS, Koss DJ, Abdi IY, Gibbons E, Guerreiro R, Bras J, International DLB Genetics Consortium, Walker L, Gelpi E, Heywood W, Outeiro TF, Attems J, McFarland R, Forsyth R, El-Agnaf OM, Erskine D. Prion-like α-synuclein pathology in the brain of infants with Krabbe disease. Brain 2022, 145(4), 1257-1263.
  • Koss DJ, Erskine D, Porter A, Palmoski P, Menon H, Todd OGJ, Leite M, Attems J, Outeiro TF. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 2022, 10, 98.
  • Toomey CE, Heywood WE, Evans JR, Lachica J, Pressey SN, Foti SC, Al Shahrani M, D'Sa K, Hargreaves IP, Heales S, Orford M, Troakes C, Attems J, Gelpi E, Palkovits M, Lashley T, Gentleman SM, Revesz T, Mills K, Gandhi S. Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's. Acta Neuropathologica Communications 2022, 10(1), 134.
  • McKenzie AT, Marx GA, Koenigsberg D, Sawyer M, Iida MA, Walker JM, Richardson TE, Campanella G, Attems J, McKee AC, Stein TD, Fuchs TJ, White CL, Farrell K, Crary JF. Interpretable deep learning of myelin histopathology in age-related cognitive impairment. Acta Neuropathologica Communications 2022, 10(1), 131.
  • Farrell K, Kim SH, Han N, Iida MA, Gonzalez EM, Otero-Garcia M, Walker JM, Richardson TE, Renton AE, Andrews SJ, Fulton-Howard B, Humphrey J, Vialle RA, Bowles KR, de Paiva Lopes K, Whitney K, Dangoor DK, Walsh H, Marcora E, Hefti MM, Casella A, Sissoko CT, Kapoor M, Novikova G, Udine E, Wong G, Tang W, Bhangale T, Hunkapiller J, Ayalon G, Graham RR, Cherry JD, Cortes EP, Borukov VY, McKee AC, Stein TD, Vonsattel J-P, Teich AF, Gearing M, Glass J, Troncoso JC, Frosch MP, Hyman BT, Dickson DW, Murray ME, Attems J, Flanagan ME, Mao Q, Mesulam M-M, Weintraub S, Woltjer RL, Pham T, Kofler J, Schneider JA, Yu L, Purohit DP, Haroutunian V, Hof PR, Gandy S, Sano M, Beach TG, Poon W, Kawas CH, Corrada MM, Rissman RA, Metcalf J, Shuldberg S, Salehi B, Nelson PT, Trojanowski JQ, Lee EB, Wolk DA, McMillan CT, Keene CD, Latimer CS, Montine TJ, Kovacs GG, Lutz MI, Fischer P, Perrin RJ, Cairns NJ, Franklin EE, Cohen HT, Raj T, Cobos I, Frost B, Goate A, White III CL, Crary JF. Genome-wide association study and functional validation implicates JADE1 in tauopathy. Acta Neuropathologica 2022, 143(1), 33-53.
  • Nelson PT, Brayne C, Flanagan ME, Abner EL, Agrawal S, Attems J, Castellani RJ, Corrada MM, Cykowski MD, Di J, Dickson DW, Dugger BN, Ervin JF, Fleming J, Graff-Radford J, Grinberg LT, Hokkanen SRK, Hunter S, Kapasi A, Kawas CH, Keage HAD, Keene CD, Kero M, Knopman DS, Kouri N, Kovacs GG, Labuzan SA, Larson EB, Latimer CS, Leite REP, Matchett BJ, Matthews FE, Merrick R, Montine TJ, Murray ME, Myllykangas L, Nag S, Nelson RS, Neltner JH, Nguyen AT, Petersen RC, Polvikoski T, Reichard RR, Rodriguez RD, Suemoto CK, Wang SJ, Wharton SB, White L, Schneider JA. Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathologica 2022, 144, 27-44.
  • Koss DJ, Bondarevaite O, Adams S, Leite M, Giorgini F, Attems J, Outeiro TF. RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies. Brain Pathology 2021, 31(1), 120-132.
  • Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, Hortobagyi T, Jellinger K, Kovacs GG, Lee EB, Love S, McAleese KE, Nelson PT, Neumann M, Parkkinen L, Polvikoski T, Sikorska B, Smith C, Grinberg LT, Thal DR, Trojanowski JQ, McKeith IG. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathologica 2021, 141(2), 159-172.
  • Kurzawa-Akanbi M, Keogh M, Tsefou E, Ramsay L, Johnson M, Keers S, Ochieng LW, McNair A, Singh P, Khan A, Pyle A, Hudson G, Ince PG, Attems J, Burn J, Chinnery PF, Morris CM. Neuropathological and Biochemical Investigation of Hereditary Ferritinopathycases with Ferritin Light Chain Mutation: Prominent Protein Aggregation in the Absence of Major Mitochondrial or Oxidative Stress. Neuropathology and Applied Neurobiology 2021, 47(1), 26-42.
  • Hamilton C, Matthews FE, Erskine D, Attems J, Thomas AJ. Neurodegenerative brain changes are associated with area deprivation in the United Kingdom: findings from the Brains for Dementia Research study. Acta Neuropathologica Communications 2021, 9, 198.
  • Hannon E, Shireby GL, Brookes K, Attems J, Sims R, Cairns NJ, Love S, Thomas AJ, Morgan K, Francis PT, Mill J. Genetic risk for Alzheimer's disease influences neuropathology via multiple biological pathways. Brain Communications 2021, 2(2), fcaa167.
  • McAleese KE, Miah M, Graham S, Hadfield GM, Walker L, Johnson M, Colloby SJ, Thomas AJ, DeCarli C, Koss D, Attems J. Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology. Acta Neuropathologica 2021, 142, 937-950.
  • Walker JM, Richardson TE, Farrell K, Iida MA, Foong C, Shang P, Attems J, Ayalon G, Beach TG, Bigio EH, Budson A, Cairns NJ, Corrada M, Cortes E, Dickson DW, Fischer P, Flanagan ME, Franklin E, Gearing M, Glass J, Hansen LA, Haroutunian V, Hof PR, Honig L, Kawas C, Keene CD, Kofler J, Kovacs GG, Lee EB, Lutz MI, Mao Q, Masliah E, McKee AC, McMillan CT, Mesulam MM, Murray M, Nelson PT, Perrin R, Pham T, Poon W, Purohit DP, Rissman RA, Sakai K, Sano M, Schneider JA, Stein TD, Teich AF, Trojanowski JQ, Troncoso JC, Vonsattel J-P, Weintraub S, Wolk DA, Woltjer RL, Yamada M, Yu L, White CL, Crary JF. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. Journal of Neuropathology and Experimental Neurology 2021, 80(2), 102-111.
  • Ivashko-Pachima Y, Hadar A, Grigg I, Korenkova V, Kapitansky O, Karmon G, Gershovits M, Sayas CL, Kooy RF, Attems J, Gurwitz D, Gozes I. Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study. Molecular Psychiatry 2021, 26, 1619-1633.
  • Oliveira FPM, Walker Z, Walker RWH, Attems J, Castanheira JC, Silva A, Oliveira C, Vaz S, Silva M, Costa DC. 123I FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases. Journal of Neurology, Neurosurgery and Psychiatry 2021, 92(6), 662-667.
  • Frost M, Keable A, Baseley D, Sealy A, Zbarcea DA, Gatherer M, Yuen HM, Sharp MM, Weller RO, Attems J, Smith C, Chiarot PR, Carare RO. Vascular α1a adrenergic receptors as a potential therapeutic target for ipad in alzheimer’s disease. Pharmaceuticals 2020, 13(9), 1-14.
  • Owasil R, O'Neill R, Keable A, Nimmo J, MacGregor Sharp M, Kelly L, Saito S, Simpson JE, Weller RO, Smith C, Attems J, Wharton SB, Yuen HM, Carare RO. The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy. International Journal of Molecular Sciences 2020, 21(4), 1225.
  • Marschallinger J, Altendorfer B, Rockenstein E, Holztrattner M, Garnweidner-Raith J, Pillichshammer N, Leister I, Hutter-Paier B, Strempfl K, Unger MS, Chishty M, Felder T, Johnson M, Attems J, Masliah E, Aigner L. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies. Neurotherapeutics 2020, 17, 1061-1074.
  • Liu KY, Reeves S, McAleese KE, Attems J, Francis P, Thomas A, Howard R. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease. Brain : a journal of neurology 2020, 143(12), 3842-3849.
  • Erskine D, Reeve AK, Polvikoski T, Schaefer AM, Taylor RW, Lax NZ, El-Agnaf O, Attems J, Gorman GS, Turnbull DM, Ng YS. Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls. Acta Neuropathologica 2020, 139, 219-221.
  • Fayyad M, Erskine D, Majbour NK, Vaikath NV, Ghanem SS, Sudhakaran IP, Abdesselem H, Lamprokostopoulou A, Vekrellis K, Morris CM, Attems J, El-Agnaf OMA. Investigating the Presence of Doubly‐phosphorylated α‐Synuclein at Tyrosine 125 and Serine 129 In Idiopathic Lewy Body Diseases. Brain Pathology 2020, 30(4), 831-843.
  • Ling H, Gelpi E, Davey K, Jaunmuktane Z, Mok KY, Jabbari E, Simone R, R'Bibo L, Brandner S, Ellis MJ, Attems J, Mann D, Halliday GM, Al-Sarraj S, Hedreen J, Ironside JW, Kovacs GG, Kovari E, Love S, Vonsattel JPG, Allinson KSJ, Hansen D, Bradshaw T, Seto-Salvia N, Wray S, de Silva R, Morris HR, Warner TT, Hardy J, Holton JL, Revesz T. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates. Acta Neuropathologica 2020, 139, 717-734.
  • McAleese KE, Walker L, Erskine D, Johnson M, Koss D, Thomas AJ, Attems J. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden. Neuropathology and Applied Neurobiology 2020, 46(7), 722-734.
  • Hatton C, Reeve A, Lax NZ, Blain A, Ng YS, El-Agnaf O, Attems J, Taylor JP, Turnbull D, Erskine D. Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies. Acta Neuropathologica Communications 2020, (8), 103.
  • Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Fardo DW, Flanagan ME, Halliday G, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murray ME, Nag S, Seeley WW, Sperling RA, White CL, Schneider JA. Reply: LATE to the PART-y. Brain 2019, 142(9), e48.
  • Tilley BS, Smith C, Pavese N, Attems J. Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration. BMJ Case Reports 2019, 12(3), e228305.
  • Erskine D, Taylor JP, Thomas A, Collerton D, McKeith I, Khundakar A, Attems J, Morris C. Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies. Neuroscience Bulletin 2019, 35, 295-300.
  • Pinho R, Paiva I, Jercic KG, Fonseca-Ornelas L, Gerhardt E, Fahlbusch C, Garcia-Esparcia P, Kerimoglu C, Pavlou MAS, Villar-Pique A, Szego E, Lopes da Fonseca T, Odoardi F, Soeroes S, Rego AC, Fischle W, Schwamborn JC, Meyer T, Kugler S, Ferrer I, Attems J, Fischer A, Becker S, Zweckstetter M, Borovecki F, Outeiro TF. Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Human Molecular Genetics 2019, 28(1), 31-50.
  • Patterson L, Firbank MJ, Colloby SJ, Attems J, Thomas AJ, Morris CM. Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign. Journal of Neuropathology and Experimental Neurology 2019, 78(8), 717–724.
  • Chai YL, Chong JR, Weng J, Howlett D, Halsey A, Lee JH, Attems J, Aarsland D, Francis PT, Chen CP, Lai MKP. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration. Brain Pathology 2019, 29(1), 63-74.
  • Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White Iii CL, Yu L, Schneider JA. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 2019, 142, 1503-1527.
  • Swarup V, Hinz FI, Rexach JE, Noguchi K, Toyoshiba H, Oda A, Hirai K, Sarkar A, Seyfried NT, Cheng C, Haggarty SJ, International Frontotemporal Dementia Genetics Consortium, (Includes, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Jaros E), Grossman M, Van Deerlin VM, Trojanowski JQ, Lah JJ, Levey AI, Kondou S, Geschwind DH. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nature Medicine 2019, 25, 152-164.
  • Bonham LW, Steele NZR, Karch CM, Broce I, Geier EG, Wen NL, Momeni P, Hardy J, Miller ZA, Gorno-Tempini ML, Hess CP, Lewis P, Miller BL, Seeley WW, Manzoni C, Desikan RS, Baranzini SE, Ferrari R, Yokoyama JS, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, Dobson-Stone C, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernandez I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Albani D, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimon J, Lleo A, Blesa R, Landqvist Waldo M, Nilsson K, Nilsson C, Mackenzie IRA, Hsiung G-YR, Mann DMA, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JCM, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Cruts M, VanBroeckhoven C, Cappa SF, Leber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Karydas AM, Rosen H, van Swieten JC, Dopper EGP, Seelaar H, Pijnenburg YAL, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang H-H, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebouvier T, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia. Scientific Reports 2019, 9, 10854.
  • Wei W, Keogh MJ, Aryaman J, Golder Z, Kullar PJ, Wilson I, Talbot K, Turner MR, McKenzie C-A, Troakes C, Attems J, Smith C, Sarraj SA, Morris CM, Ansorge O, Jones NS, Ironside JW, Chinnery PF. Frequency and signature of somatic variants in 1461 human brain exomes. Genetics in Medicine 2019, 21, 904-912.
  • McAleese KE, Graham S, Dey M, Walker L, Erskine D, Johnson M, Johnston E, Thomas AJ, McKeith IG, DeCarli C, Attems J. Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease. Brain Pathology 2019, 29(3), 414-424.
  • Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn DJ, Donaghy P, Morris CM, Taylor JP, Thomas AJ, Attems J, McKeith IG. Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration 2019, 14, 5.
  • Patterson L, Rushton SP, Attems J, Thomas AJ, Morris CM. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders. Brain Pathology 2019, 29(4), 544-557.
  • Szego EM, Dominguez-Meijide A, Gerhardt E, Konig A, Koss DJ, Li W, Pinho R, Fahlbusch C, Johnson M, Santos P, Villar-Pique A, Thom T, Rizzoli S, Schmitz M, Li J, Zerr I, Attems J, Jahn O, Outeiro TF. Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies. Cell Reports 2019, 28(1), 65-77.e6.
  • Nicolas G, Acuna-Hidalgo R, Keogh MJ, Quenez O, Steehouwer M, Lelieveld S, Rousseau S, Richard A-C, Oud MS, Marguet F, Laquerriere A, Morris CM, Attems J, Smith C, Ansorge O, Al Sarraj S, Frebourg T, Campion D, Hannequin D, Wallon D, Gilissen C, Chinnery PF, Veltman JA, Hoischen A. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease. Alzheimer's and Dementia 2018, 14(12), 1632-1639.
  • Hadar A, Milanesi E, Walczak M, Puzianowska-Kuznicka M, Kuznicki J, Squassina A, Niola P, Chillotti C, Attems J, Gozes I, Gurwitz D. SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease. Scientific Reports 2018, 8(1), 8465.
  • Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM. Regional levels of physiological α-synuclein are directly associated with Lewy body pathology. Acta Neuropathologica 2018, 135(1), 153-154.
  • Neddens J, Temmel M, Flunkert S, Kerschbaumer B, Hoeller C, Loeffler T, Niederkofler V, Daum G, Attems J, Hutter-Paier B. Phosphorylation of different tau sites during progression of Alzheimer's disease. Acta Neuropathologica Communications 2018, 6(1), 52.
  • Carroll B, Otten E, Manni D, Stefanatos R, Menzies F, Smith G, Jurk D, Kenneth N, Wilkinson S, Passos J, Attems J, Veal E, Teyssou E, Seilhean D, Millecamps S, Eskelinen E-L, Bronowska A, Rubinsztein DC, Sanz A, Korolchuk V. Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis. Nature Communications 2018, 9, 256.
  • Keogh MJ, Wei W, Aryaman J, Wilson I, Talbot K, Turner MR, McKenzie C-A, Troakes C, Attems J, Smith C, AlSarraj S, Morris CM, Ansorge O, Pickering-Brown S, Jones N, Ironside JW, Chinnery PF. Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains. Journal of Neurology, Neurosurgery and Psychiatry 2018, 89(8), 813-816.
  • Sutovsky S, Smolek T, Turcani P, Petrovic R, Brandoburova P, Jadhav S, Novak P, Attems J, Zilka N. Neuropathology and biochemistry of early onset familial Alzheimer’s disease caused by presenilin-1 missense mutation Thr116Asn. Journal of Neural Transmission 2018, 125(6), 965-976.
  • Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM. Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies. Movement Disorders 2018, 33(6), 982-991.
  • Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia. Alzheimer's Research and Therapy 2018, 10(1), 27.
  • Keogh MJ, Wei W, Aryaman J, Walker L, van den Ameele J, Coxhead J, Wilson I, Bashton M, Beck J, West J, Chen R, Haudenschild C, Bartha G, Luo S, Morris CM, Jones NS, Attems J, Chinnery PF. High prevalence of focal and multi-focal somatic genetic variants in the human brain. Nature Communications 2018, 9(1), 4257.
  • Unger MS, Marschallinger J, Kaindl J, Klein B, Johnson M, Khundakar AA, Roßner S, Heneka MT, Couillard-Despres S, Rockenstein D, Masliah E, Attems J, Aigner L. Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?. Alzheimer's & Dementia 2018, 14(8), 1022-1037.
  • Lloyd JJ, Petrides G, Donaghy PC, Colloby SJ, Attems J, O'Brien JT, Roberts G, Thomas AJ. A new visual rating scale for Ioflupane imaging in Lewy body disease. NeuroImage: Clinical 2018, 20, 823-829.
  • Mcaleese KE, Walker L, Erskine D, Thomas AJ, Mckeith IG, Attems J. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing. Brain Pathology 2017, 27(4), 472-479.
  • Manousopoulou A, Gatherer M, Smith C, Nicoll JAR, Woelk CH, Johnson M, Kalaria R, Attems J, Garbis SD, Carare RO. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology 2017, 43(6), 492-504.
  • Erskine D, Thomas AJ, Attems J, Taylor JP, McKeith IG, Morris CM, Khundakar AA. Specific patterns of neuronal loss in the pulvinar nucleus in dementia with Lewy bodies. Movement Disorders 2017, 32(3), 414-422.
  • Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J. Quantitative neuropathology: an update on automated methodologies and implicationsfor large scale cohorts. Journal of Neural Transmission 2017, 124(6), 671-683.
  • McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor J-P, Thomas AJ, McKeith IG, De Carli C, Attems J. Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathologica 2017, 134(3), 459-473.
  • Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA. Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies. The American Journal of Geriatric Psychiatry 2017, 25(6), 595-604.
  • Wei W, Keogh MJ, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akanbi M, Santibanez-Koref M, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Al Sarraj S, Morris CM, Ansorge O, Pickering-Brown S, Ironside JW, Chinnery PF. Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains. Acta Neuropathologica Communications 2017, 5, 17.
  • Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathologica 2017, 134(2), 187-205.
  • Keogh MJ, Wei W, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akanbi M, Santibariez-Koref M, Talbot K, Turner MR, McKenzie CA, Troakes C, Attems J, Smith C, Al Sarraj S, Morris CM, Ansorge O, Pickering-Brown S, Ironside JW, Chinnery PF. Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource. Genome Reseach 2017, 27(1), 165-173.
  • Pirici D, Stanaszek L, Garz C, Niklass S, Heinze H-J, Kalinski T, Attems J, Schreiber S. Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP. Brain Pathology 2017, 27(2), 169-180.
  • Thomas AJ, Attems J, Colloby SJ, O'Brien JT, Mckeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Autopsy validation of ¹²³ I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 2017, 88(3), 276-283.
  • Skrobot OA, Attems J, Esiri M, Hortobágyi, T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain 2016, 139(11), 2957-2969.
  • Baek JH, Whitfield D, Howlett D, Francis P, Bereczki E, Ballard C, Hortobagyi T, Attems J, Aarsland D. Unfolded protein response is activated in Lewy body dementias. Neuropathology and Applied Neurobiology 2016, 42(4), 352-365.
  • Maj M, Hoermann G, Rasul S, Base W, Wagner L, Attems J. The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells. Journal of Diabetes Research 2016, 2016, 1964634.
  • Bereczki E, Francis PT, Howlett D, Pereira JB, Hoglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobagyi T, Attems J, Ballard C, Aarsland D. Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia. Alzheimer's & Dementia 2016, 12(11), 1149-1158.
  • Plum S, Steinbach S, Attems J, Keers S, Riederer P, Gerlach M, May C, Marcus K. Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection. Scientific Reports 2016, 6, 37139.
  • McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kovari E, Love S, Popovic M, Skrobot O, Taipa R, Thal DR, Werring D, Wharton SB, Attems J. Post-mortem assessment in vascular dementia: advances and aspirations. BMC Medicine 2016, 14, 129.
  • Perneczky R, Tene O, Attems J, Giannakopoulos P, Ikram MA, Federico A, Sarazin M, Middleton LT. Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group. BMC Medicine 2016, 14(1), 162.
  • Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, Chinnery PF. Exome sequencing in dementia with Lewy bodies. Translational Psychiatry 2016, 6, e728.
  • Keable A, Fenna K, Yuen HM, Johnston DA, Smyth NR, Smith C, Salman RAS, Samarasekera N, Nicoll JAR, Attems J, Kalaria RN, Weller RO, Carare RO. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochimica et Biophysica Acta - Molecular Basis of Disease 2016, 1862(5), 1037-1046.
  • Gatt AP, Duncan OF, Attems J, Francis PT, Ballard CG, Bateman JM. Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency. Movement Disorders 2016, 31(3), 352-359.
  • Vallortigara J, Whitfield D, Quelch W, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, O'Brien JT, Thomas A, Ballard CG, Aarsland D, Francis PT. Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. Journal of Alzheimer's Disease 2016, 50(1), 101-110.
  • Zhang M-D, Barde S, Szodorai E, Josephson A, Mitsios N, Watanabe M, Attems J, Lubec G, Kovacs GG, Uhlen M, Mulder J, Harkany T, Hokfelt T. Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord. Brain Structure and Function 2016, 221(7), 3803-3823.
  • Vergani F, Martino J, Morris C, Attems J, Ashkan K, Dell'Acqua F. Anatomic Connections of the Subgenual Cingulate Region. Neurosurgery 2016, 79(3), 465-472.
  • Khundakar AA, Hanson PS, Erskine D, Lax NZ, Roscamp J, Karyka E, Tsefou E, Singh P, Cockell SJ, Gribben A, Ramsay L, Blain PJ, Mosimann UP, Lett DJ, Elstner M, Turnbull DM, Xiang CC, Brownstein MJ, O'Brien JT, Taylor JP, Attems J, Thomas AJ, McKeith IG, Morris CM. Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations. Acta Neuropathologica Communications 2016, 4, 66.
  • Lee C, Low CYB, Francis PT, Attems J, Wong PTH, Lai MKP, Tan MGK. An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease. Journal of Neurochemistry 2016, 136(3), 637-650.
  • Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobagyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kovari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemuller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL, Wisniewski T, Woulfe JM, Yamada M, Dickson DW. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica 2016, 131(1), 87-102.
  • Spilsbury A, Miwa S, Attems J, Saretzki G. The Role of Telomerase Protein TERT in Alzheimer's Disease and in Tau-Related Pathology In Vitro. Journal of Neuroscience 2015, 35(4), 1659-1674.
  • Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, Ballard CG, on behalf of The Medical Research Council Cognitive Function and Ageing Neuropathology Study. Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer's Disease. Biological Psychiatry 2015, 77(8), 711-719.
  • Howlett DR, Whitfield D, Johnson M, Attems J, O'Brien JT, Aarsland D, Lai MKP, Lee JH, Chen C, Ballard C, Hortobagyi T, Francis PT. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias. Brain Pathology 2015, 25(4), 401-408.
  • Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathologica 2015, 129(5), 729-748.
  • Thal DR, von Arnim CAF, Griffin WST, Mrak RE, Walker L, Attems J, Arzberger T. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. Journal of Neural Transmission 2015, 122(7), 1007-1018.
  • Ziso B, Williams TL, Walters RJL, Jaiser SR, Attems J, Wieshmann UC, Larner AJ, Jacob A. Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy. Case Reports in Neurology 2015, 7(1), 95-100.
  • McAleese K, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, Beverley JR, Taylor JP, Thomas AJ, O'Brien JT, Attems J. Cortical tau load is associated with white matter hyperintensities. Acta Neuropathologica Communications 2015, 3, 60.
  • Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG. Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β Normal 0 false false false EN-GB X-NONE X-NONE -amyloid load. Neurology 2015, 84(5), 496-499.
  • Erskine D, Taylor JP, Firbank MJ, Patterson L, Onofrj M, O'Brien JT, McKeith IG, Attems J, Thomas AJ, Morris CM, Khundakar AA. Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies. Neuropathology and Applied Neurobiology 2015, 42(4), 366–376.
  • Vergani F, Lacerda L, Martino J, Attems J, Morris C, Mitchell P, de Schotten MT, Dell'Acqua F. White matter connections of the supplementary motor area in humans. Journal of Neurology, Neurosurgery & Psychiatry 2014, 85(12), 1377-1385.
  • Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer's disease - lessons from pathology. BMC Medicine 2014, 12(1), 206.
  • Mandler M, Walker L, Santic R, Hanson P, Upadhaya AR, Colloby SJ, Morris CM, Thal DR, Thomas AJ, Schneeberger A, Attems J. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease. Acta Neuropathologica 2014, 128(1), 67-79.
  • Steinacker P, Berner C, Thal DR, Attems J, Ludolph AC, Otto M. Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot. Acta Neuropathologica Communications 2014, 2, 130.
  • Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL, Wisniewski T, Woltjer RL, Yamada M, Nelson PT. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica 2014, 128(6), 755-766.
  • Schreiber S, Drukarch B, Garz C, Niklass S, Stanaszek L, Kropf S, Bueche C, Held F, Vielhaber S, Attems J, Reymann KG, Heinze H-J, Carare RO, Wilhelmus MMM. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: Longitudinal studies in hypertensive stroke-prone rats. Journal of Alzheimer's Disease 2014, 42, S205-S215.
  • Fuchs E-M, Kostler WJ, Horvat R, Hudelist G, Kubista E, Attems J, Zielinski CC, Singer CF. High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting. International Journal of Cancer 2014, 135(1), 224-231.
  • Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernandez I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimon J, Lleo A, Blesa R, Waldo ML, Nilsson K, Nilsson C, Mackenzie IRA, Hsiung GYR, Mann DMA, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JCM, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EGP, Seelaar H, Al Pijnenburg Y, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurology 2014, 13(7), 686-699.
  • Vallortigara J, Rangarajan S, Whitfield D, Alghamdi A, Howlett D, Hortobagyi T, Johnson M, Attems J, Ballard C, Thomas A, O'Brien J, Aarsland D, Francis P. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000Research 2014, 3, 108.
  • Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. American Journal of Neurodegenerative Diseases 2014, 3(1), 19-32.
  • Whitfield DR, Vallortigara J, Alghamdi A, Howlett D, Hortobagyi T, Johnson M, Attems J, Newhouse S, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Francis PT. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment. Neurobiology of Aging 2014, 35(12), 2836-2844.
  • Veitinger M, Oehler R, Umlauf E, Baumgartner R, Schmidt G, Gerner C, Babeluk R, Attems J, Mitulovic G, Rappold E, Lamont J, Zellner M. A platelet protein biochip rapidly detects an Alzheimer’s disease-specific phenotype. Acta Neuropathologica 2014, 128(5), 665-677.
  • Akinyemi R, Mukaetova-Ladinska E, Attems J, Ihara M, Kalaria RN. Vascular Risk Factors and Neurodegeneration in Ageing related Dementias: Alzheimer's Disease and Vascular Dementia. Current Alzheimer Research 2013, 10(6), 642-653.
  • Thal DR, Von Arnim C, Griffin WST, Yamaguchi H, Mrak RE, Attems J, Upadhaya AR. Pathology of clinical and preclinical alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience 2013, 263(Suppl. 2), 137-145.
  • Lendvai D, Morawski M, Negyessy L, Gati G, Jager C, Baksa G, Glasz T, Attems J, Tanila H, Arendt T, Harkany T, Alpar A. Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathologica 2013, 125(2), 215-229.
  • McAleese KE, Firbank M, Hunter D, Sun L, Hall R, Neal JW, Mann DM, Esiri M, Jellinger KA, O'Brien JT, Attems J. Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathology and Applied Neurobiology 2013, 39(5), 485-497.
  • Yamamoto Y, Craggs LJL, Watanabe A, Booth T, Attems J, Low RWC, Oakley AE, Kalaria RN. Brain Microvascular Accumulation and Distribution of the NOTCH3 Ectodomain and Granular Osmiophilic Material in CADASIL. Journal of Neuropathology and Experimental Neurology 2013, 72(5), 416-431.
  • Alpar A, Attems J, Mulder J, Hokfelt T, Harkany T. The renaissance of Ca(2+)-binding proteins in the nervous system: secretagogin takes center stage. Cellular Signalling 2012, 24(2), 378-387.
  • Jellinger KA, Attems J. Neuropathology and general autopsy findings in nondemented aged subjects. Clinical Neuropathology 2012, 31(2), 87-98.
  • Colloby SJ, McParland S, O'Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain 2012, 135(9), 2798-808.
  • Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease 2012, 47(2), 155-162.
  • Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E. Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients. Journal of Proteomics 2012, 75(7), 2080-2092.
  • Attems J, Alpar A, Spence L, McParland S, Heikenwalder M, Uhlén M, Tanila H, Hökfelt TG, Harkany T. Clusters of secretagogin-expressing neurons in the aged human olfactory tract lack terminal differentiation. Proceedings of the National Academy of Sciences 2012, 109(16), 6259-6264.
  • Watabe Rudolph M, Song Z, Lausser L, Schnack C, Begus Nahrmann Y, Scheithauer MO, Rettinger G, Otto M, Tumani H, Thal DR, Attems J, Jellinger KA, Kestler HA, von Arnim CA, Rudolph KL. Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology 2012, 78(8), 569-577.
  • Kovacs GG, Wohrer A, Strobel T, Botond G, Attems J, Budka H. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. Clinical Neuropathology 2011, 30(1), 3-10.
  • Attems J, Jellinger K, Thal DR, Van Nostrand W. Sporadic cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology 2011, 37(1), 75-93.
  • Attems J, Ittner A, Jellinger K, Nitsch RM, Maj M, Wagner L, Gotz J, Heikenwalder M. Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice. Journal of Neural Transmission 2011, 118(5), 737-745.
  • Jellinger KA, Attems J. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dementia and Geriatric Cognitive Disorders 2011, 31(4), 309-316.
  • Maj M, Ilhan A, Neziri D, Gartner W, Berggard T, Attems J, Base W, Wagner L. Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer's pathology. World Journal of Diabetes 2011, 2(4), 49-53.
  • Jellinger KA, Attems J. Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathologica 2010, 119(4), 421-433.
  • Jellinger KA, Attems J. Prevalence and pathology of vascular dementia in the oldest old. Journal of Alzheimer's Disease 2010, 21(4), 1283-1293.
  • Jellinger K, Attems J. Is there pure vascular dementia in old age?. Journal of the Neurological Sciences 2010, 299(1-2), 150-154.
  • Maj M, Gartner W, Ilhan A, Neziri D, Attems J, Wagner L. Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin. Journal of Endocrinology 2010, 205(1), 25-36.
  • Fuchs EM, Kostler WJ, Horvat R, Hudelist G, Dressler C, Pfeiler G, Fink-Retter A, Gschwantler-Kaulich D, Attems J, Zielinski CC, Singer CF. ErbB2/CEP17 and total ErbB2 copy number as independent forecast factor for time to First Metastasis (TTM) and with a trastuzumab-based therapy in HER2 testing metasase breast cancer [abstract]. Geburtshilfe und Frauenheilkunde 2010, 70(3), 245.
  • Watzka SB, Rauscher-Potsch I, Nierlich P, Setinek U, Kostler WJ, Potschger U, Muller MR, Attems J. Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study. European Journal of Cardio-Thoracic Surgery 2010, 38(1), 34-37.
  • Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kolsch H, Tredici KD, Attems J, Ghebremedhin E. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease. Acta Neuropathologica 2010, 120(2), 169-183.
  • Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, Knoll P, Zajicek B, Dudczak R, Mostbeck G, Kuntner C, Langer O, Bruecke T, Mirzaei S. Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment. Current Alzheimer Research 2009, 6(3), 312-319.
  • Zagler C, Cichon P, Setinek U, Attems J, Prosch H, Vetter N, Armbruster C. [abstract] The abscess formation by Cryptococcus neoformans with underlying Sarcoide and distinct immunodeficiency. Wiener Klinische Wochenschrift 2009, 120(13-14), A35.
  • Watzka SB, Nierlich P, Setinek U, Koestler WJ, Mueller MR, Attems J. [abstract] EGFR status of primary NSCLC remains unchanged in lymph node and organ metastases: An autopsy study. Lung Cancer 2009, 64(s1), S54.
  • Zwick R, Muller M, Attems J, Burghuber OC. [abstract] A 18-year-old Girl with Fever, Cough, and cystic Lesions in the Lungs. Wiener Klinische Wochenschrift 2009, 121(17-18), A65-A66.
  • Attems J, Lauda F, Jellinger KA. Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. Journal of Neurology 2008, 255(1), 70-76.
  • Attems J, Jellinger KA. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease. Neuropathology and Applied Neurobiology 2008, 34(4), 466-467.
  • Jellinger KA, Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathologica 2008, 115(4), 427-436.
  • Armbruster C, Huber M, Prosch H, Dworan N, Attems J. Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: different features of a rare neoplasm. Onkologie 2008, 31(4), 179-184.
  • Jellinger KA, Attems J. Cerebral amyloid angiopathy in Lewy body disease. Journal of Neural Transmission 2008, 115(3), 473-482.
  • Attems J, Preusser M, Grosinger-Quass M, Wagner L, Lintner F, Jellinger K. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Neuropathology and Applied Neurobiology 2008, 34(1), 23-32.
  • Jellinger KA, Janetzky B, Attems J, Kienzl E. Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'-a new blood biomarker?. Journal of Cellular and Molecular Medicine 2008, 12(4), 1094-1117.
  • Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. Journal of the Neurological Sciences 2007, 257(1-2), 49-55.
  • Attems J, Quass M, Jellinger KA. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathologica 2007, 113(1), 53-62.
  • Jellinger KA, Lauda F, Attems J. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. European Journal of Neurology 2007, 14(8), 923-928.
  • Jellinger KA, Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathologica 2007, 113(2), 107-117.
  • Hudelist G, Wagner T, Rosner M, Fink-Retter A, Gschwantler-Kaulich D, Czerwenka K, Kroiss R, Tea M, Pischinger K, Kostler WJ, Attems J, Mueller R, Blaukopf C, Kubista E, Hengstschlager M, Singer CF. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocrine-Related Cancer 2007, 14(4), 1053-1062.
  • Attems J, Quass M, Gartner W, Nabokikh A, Wagner L, Steurer S, Arbes S, Lintner F, Jellinger K. Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons. Experimental Gerontology 2007, 42(3), 215-222.
  • Sutterluty H, Mayer CE, Setinek U, Attems J, Ovtcharov S, Mikula M, Mikulits W, Micksche M, Berger W. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Molecular Cancer Research 2007, 5(5), 509-520.
  • Huber M, Rumetshofer R, Stradal KH, Attems J, Lintner F. Catheter-related Leuconostoc bacteremia secondary to pulmonary Mycobacterium xenopi infection. Wien Klin Wochenschr 2007, 119(21-22), 674-677.
  • Jellinger KA, Attems J. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurologica Scandinavica 2006, 114(1), 38-46.
  • Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clinical Neuropathology 2006, 25(6), 265-271.
  • Huber M, Pohl W, Reinisch G, Attems J, Pescosta S, Lintner F. Lung disease 35 years after aspiration of activated charcoal in combination with pulmonary lymphangioleiomyomatosis. A histological and clinicopathological study with scanning electron microscopic evaluation and element analysis. Virchows Archiv 2006, 449(2), 225-229.
  • Attems J, Jellinger K. Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology 2006, 66(5), 775.
  • Hudelist G, Kostler WJ, Czerwenka K, Kubista E, Attems J, Muller R, Gschwantler-Kaulich D, Manavi M, Huber I, Hoschutzky H, Zielinski CC, Singer CF. Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer. International Journal of Cancer 2006, 118(5), 1126-1134.
  • Jellinger KA, Attems J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?. Acta Neuropathologica 2006, 112(3), 253-60.
  • Jellinger KA, Attems J, Quass M, Lintner F. [abstract] Tau and alpha-syunclein brainstem lesions in Alzheimer disease. Journal of Neural Transmission 2006, 113(6), VII.
  • Kostler WJ, Brodowicz T, Hudelist G, Rudas M, Horvat R, Steger GG, Singer CF, Attems J, Rabitsch W, Fakhrai N, Elandt K, Wiltschke C, Hejna M, Zielinski CC. The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status. Journal of Cancer Research and Clinical Oncology 2005, 131(7), 420-428.
  • Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathologica 2005, 110(4), 345-359.
  • Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. Journal of the Neurological Sciences 2005, 229-230, 37-41.
  • Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. Journal of Alzheimer's Disease 2005, 7(2), 149-57; discussion 173-80.
  • Berger W, Setinek U, Hollaus P, Zidek T, Steiner E, Elbling L, Cantonati H, Attems J, Gsur A, Micksche M. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. Journal of Cancer Research and Clinical Oncology 2005, 131(6), 355-363.
  • Attems J, Konig C, Huber M, Lintner F, Jellinger KA. Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. Journal of Alzheimer's Disease 2005, 8(1), 57-62.
  • Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathologica 2005, 110(3), 222-231.
  • Jellinger KA, Attems J. Alzheimer pathology in the olfactory bulb. Neuropathology and Applied Neurobiology 2005, 31(2), 203.
  • Attems J, Arbes S, Bohm G, Bohmer F, Lintner F. The clinical diagnostic accuracy rate regarding the immediate cause of death in a hospitalized geriatric population; an autopsy study of 1594 patients. Wiener Medizinische Wochenschrift 2004, 154(7-8), 159-162.
  • Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathologica 2004, 107(2), 83-90.
  • Attems J, Lintner F, Jellinger KA. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathologica 2004, 107(4), 283-291.
  • Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathologica 2003, 105(1), 14-17.
  • Hudelist G, Kostler WJ, Attems J, Czerwenka K, Muller R, Manavi M, Steger GG, Kubista E, Zielinski CC, Singer CF. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. British Journal of Cancer 2003, 89(6), 983-991.
  • Attems JH, Lintner F. Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features. Pathology, Research and Practice 2001, 197(12), 841-846.

• Book Chapters

  • Walker L, McAleese KE, Erskine D, Attems J. Neurodegenerative Diseases and Ageing. In: Subcellular Biochemistry. Singapore: Springer Nature, 2019, pp.75-106.
  • Attems J, McAleese KE, Walker L. Methods for pathological classification of Alzheimer's disease. In: Robert Perneczky, ed. Biomarkers for Preclinical Alzheimer's Disease. New York, NY, USA: Humana Press, 2018, pp.71-89.
  • Kalaria RN, Attems J. Microvascular Pathology. In: Michael J. Aminoff and Robert B. Daroff, ed. Encyclopedia of the Neurological Sciences. Elsevier Inc, 2014, pp.21-25.
  • Attems J, Thal DR. Amyloidosis. In: Encyclopedia of the Neurological Sciences. Elsevier Inc, 2014, pp.158-164.

• Conference Proceedings (inc. Abstracts)

  • Skrobot OA, Attems J, Esiri M, Hortobagyi T, Ironside J, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S. Vascular Cognitive Impairment Neuropathology Guidelines (VCING) - a UK multi-centre consensus study. In: 117th Meeting of the British Neuropathological Society. 2016, London, UK: Wiley-Blackwell Publishing Ltd.
  • McAleese KE, Walker L, Erskine D, Attems J. The prevalence of TDP-43 pathology in Alzheimer's disease, Lewy body dementia and mixed Alzheimer's disease and Lewy body disease. In: 17th meeting of the British Neuropathological Society. 2016, London, UK: Wiley-Blackwell.
  • Walker L, Thomas A, Lett DJ, McAleese KE, Johnson M, Attems J. Investigating the pathological correlate of motor dysfunction in DLB and PDD. In: 117th meeting of the British Neuropathological Society. 2016, London: Wiley-Blackwell Publishing Ltd.
  • Manousopoulou A, Smith C, Nicoll JAR, Attems J, Kalaria R, Johnston HE, Woelk CH, Weller RO, Garbis SD, Carare RO. Global proteomic profiling of brain leptomeningeal arteries from patients with cerebral amyloid angiopathy reveals novel therapeutic targets. In: 116th Meeting of the British Neuropathological Society. 2015, London, UK: Wiley-Blackwell.
  • Jaiser S, Attems J, Williams T. A case of facial onset sensory and motor neuronopathy (FOSMN) associated with TDP-43 proteinopathy. In: 1st Congress of the European Academy of Neurology. 2015, Berlin, Germany: Wiley-Blackwell Publishing Ltd.
  • Walker L, Thomas AJ, Attems J. Quantification of pathological lesions detects clinico-pathological phenotypes of mixed AD/LBD. In: BRAIN PATHOLOGY. 2014, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL.
  • Attems J, Walker L, Santic R, Colloby SJ, Upadhaya AR, Thal DR, Schneeberger A, Mandler M. Pyroglutamylated amyloid-beta is associated with hyperphosphorylated tau in human post mortem brains. In: 115th Meeting of the British Neuropathological Society. 2014, London: Wiley-Blackwell.
  • Attems J, Walker L, Santic R, Upadhaya AR, Colloby S, Thal D, Thomas A, Schneeberger A, Mandler M. Pyroglutamylated Amyloid-beta correlates with Hyperphosphorylated Tau and Severity of Alzheimer's Disease. In: American Association of Neuropathologists, Inc. 90th Annual Meeting. 2014, Portland, OR, USA: Lippincott Williams & Wilkins, Ltd.
  • Jellinger KA, Walker L, Attems J. Olfactory neurodegenerative pathology in neurodegenerative diseases. In: 115th Meeting of the British Neuropathological Society. 2014, London, UK: Wiley-Blackwell Publishing Ltd.
  • Johnson M, Perry EK, Baker C, Attems J. Neurogenic marker alterations in the hippocampus in relation to cholinergic therapy in Lewy Body dementia. In: Proceedings of the 115th Meeting of the British Neuropathological Society. 2014, London: Wiley-Blackwell.
  • McAleese KE, Dey M, Firbank M, McParland S, O'Brien JT, Attems J. Cortical neurodegenerative pathology has an influence on white matter integrity. In: 115th Meeting of the British Neuropathological Society. 2014, London, UK: Wiley-Blackwell Publishing Ltd.
  • McParland S, McAleese K, Walker L, Johnson M, Fielder E, Knowles I, Attems J. Tissue microarray in the quantification of hyper-phosphorylated tau, amyloid-beta and alpha-synuclein. In: 114th Meeting of the British Neuropathological Society. 2013, London: Wiley-Blackwell Publishing Ltd.
  • Walker L, Thomas AJ, Morris CM, Attems J. Quantification of pathology in mixed Alzheimer's disease and Lewy body dementia. In: 114th Meeting of the British Neuropathological Society: Symposium on Advances in Motor Neuron Diseases. 2013, London: Wiley-Blackwell Publishing Ltd.
  • Bodi I, Troakes C, Maekawa S, Attems J, Esiri MM, Hortobagyi T, King A, Love S, Mann D, Neal JW, Al-Sarraj S. Diagnostic approach to Argyrophilic Grain Disease (AGD): an UK BDR trial. In: Proceedings of the 114th Meeting of the British Neuropathological Society, Institute of Child Health. 2013, London: Wiley-Blackwell.
  • Yamamoto Y, Craggs LJL, Watanabe A, Attems J, Low RWC, Oakley AE, Kalaria RN. Brain microvascular accumulation and distribution of GOM and the NOTCH3 ectodomain in CADASIL. In: 114th Meeting of the British Neuropathological Society: Symposium on Advances in Motor Neuron Diseases. 2013, London: Wiley-Blackwell Publishing Ltd.
  • McAleese K, Firbank M, McParland S, Attems J. Axonal degeneration secondary to cortical neurodegeneration; a potential cause for white matter lesions?. In: 114th Meeting of British Neuropathological Society. 2013, London, UK: Wiley-Blackwell Publishing Ltd.
  • McAleese KE, Firbank M, Johnson M, Walker L, Hunter D, Sun L, Hall R, O'Brien JT, Attems J. Magnetic resonance imaging detects subcortical vascular pathology in post mortem brains. In: 113th Meeting of the British Neuropathological Society. 2012, London, UK.
  • McAleese KE, Firbank M, Johnson M, Walker L, Hunter D, Sun L, Hall R, O'Brien JT, Attems J. Magnetic resonance imaging detects subcortical vascular pathology in post mortem brains. In: 10th European Congress of Neuropathology. 2012, Edinburgh, Scotland.
  • Craggs LJL, Yamamoto Y, Watanabe A, Low WC, Slade JY, Attems J, Oakley AE, Kalaria RN. Cerebral Accumulation, Distribution and Clearance of GOM and NOTCH3 fragments in CADASIL. In: 10th European Congress on Neuropathology. 2012, Edinburgh International Conference Centre (EICC), Edinburgh, Scotland, UK.
  • Esiri M, Attems J, Bodi I, Deramecourt V, Hortobagyi T, Joachim C, Kalaria RN, King A, Mann DM, Morris JH, Neal J, Oulhaj A, Al-Sarraj S. The semi-quantitative assessment of subcortical small vessel disease pathology in elderly subjects: an initiative from the UK BD collaboration. In: 112th Meeting of the British Neuropathological Society. 2011, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Jellinger K, Attems J. Tangle dominant dementia - comparison with classical Alzheimer disease. In: 112th Meeting of the British Neuropathological Society. 2011, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Attems J, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kolsch H, Tredici KD, Ghebremedhin E, Thal DR. Capillary CAA defines a subtype of Alzheimer's disease while pericapillary A beta is a type of early A beta deposition. In: Proceedings of the 112th Meeting of the British Neuropathological Society. 2011, Wiley-Blackwell Publishing Ltd.
  • Jellinger KA, Attems J. Is there pure vascular dementia in old age?. In: 1st Congress on Vascular Dementia (VaD). 2010, Geneva, Switzerland: Journal of the Neurological Sciences: Elsevier BV.
  • Attems J, Yamaguchi H, Saido TC, Thal DR. Capillary CAA and perivascular Abeta-deposition. In: 17th International Congress of Neuropathology (ICN). 2010, Salzburg, Austria: Brain Pathology: Wiley-Blackwell.
  • Attems J, Yamaguchi H, Saido TC, Thal DR. Capillary CAA and perivascular A beta-deposition: Two distinct features of Alzheimer's disease pathology. In: 1st Congress on Vascular Dementia (VaD). 2010, Geneva, Switzerland: Journal of the Neurological Sciences: Elsevier BV.
  • Jellinger KA, Attems J, Lauda F. Sporadic cerebral amyloid angiopathy-No frequent cause of spontaneous brain hemorrhage in the aged. In: 5th International Congress on Vascular Dementia. 2009, Budapest, Hungary: Journal of the Neurological Sciences: Elsevier BV.
  • Attems J, Jellinger K. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies. In: 110th Annual Meeting of the British Neuropathological Society. 2009, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Attems J. Neuropathology of age-associated neurodegenerative diseases. In: Wiener Klinische Wochenschrift: International Conference on Ageing. 2009, Beijing, China: Springer Wien.
  • Lauda F, Jellinger K, Attems J. Different Neprilysin expression in vessels of occipital and frontal lobes. In: 54th Annual Meeting of the German Society of Neuropathology and Neuroanatomy. 2009, Dusseldorf, Germany: Acta Neuropathologica: Springer.
  • Attems J, Heikenwalder M, Aguzzi A, Wagner L, Nitsch R, Jellinger K. Secretagogin is expressed in hippocampal neurones of wild type but not of tau-homocygote (P301L) mice. In: 109th Annual Meeting of the British Neuropathological Society. 2008, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Jellinger KA, Attems J. Neuropathology of Parkinson's disease Dementia (PDD) and Dementia with Lewy bodies (DLB). In: 53rd Annual Meeting of the German Society of Neuropathology and Neuroanatomy. 2008, Wurzburg, Germany: Acta Neuropathologica: Springer.
  • Jellinger KA, Attems J. Cerebral amyloid angiopathy in Lewy body disease. In: 109th Annual Meeting of the British Neuropathological Society. 2008, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Attems J, Heikenwalder M, Aguzzi A, Wagner L, Nitsch R, Jellinger K. Calcium binding protein secretagogin and neuroprotection in Alzheimer's disease. In: 53rd Annual Meeting of the German Society of Neuropathology and Neuroanatomy. 2008, Wurzburg, Germany: Acta Neuropathologica: Springer.
  • Attems J, Grosinger-Quass M, Lintner F, Jellinger KA. Secretagogin expressing neurons in the human hippocampus are resistant to neurodegeneration in Alzheimer's disease. In: 108th Annual Meeting of the British Neuropathological Society. 2007, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Haigl B, Mayer CE, Mohr T, Micksche M, Attems J, Berger W, Sutterluty H. Mechanisms involved in the regulation of Sprouty4 expression. In: 32nd Congress of the Federation of European Biochemical Societies (FEBS). 2007, Vienna, Austria: FEBS Journal: Wiley-Blackwell.
  • Attems J, Jellinger KA. Tau and alpha-synuclein brainstem pathology in Alzheimer disease. In: 107th Annual Meeting of the British Neuropathological Society. 2006, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Hudelist G, Wagner T, Fink-Retter A, Gschwantler-Kaulich D, Czerwenka K, Kroiss R, Muy-Kheng T, Pischinger K, Koestler W, Attems J, Mueller R, Blaukopf C, Kubista E, Singer C. Intratumoral IGF-1 protein expression is selectively up-regulated in breast cancer patients with BRCA1/2 mutations. In: 29th Annual San Antonio Breast Cancer Symposium. 2006, San Antonio, Texas, USA: Breast Cancer Research and Treatment: Springer New York LLC.
  • Jellinger KA, Attems J. Tau and alpha-synuclein brainstem pathology in Alzheimer disease. In: 50th Annual Meeting of the German Society of Neuropathology and Neuroanatomy. 2005, Graz, Austria: Acta Neuropathologica: Springer.
  • Attems J, Jellinger KA, Lintner F. Olfactory pathology in aging and Alzheimer disease. In: 50th Annual Meeting of the German Society of Neuropathology and Neuroanatomy. 2005, Graz, Austria: Acta Neuropathologica: Springer.
  • Attems J, Jellinger KA, Lintner F. Olfactory involvement in ageing and Alzheimer disease. In: 106th Annual Meeting of the British Neuropathological Society. 2005, London, UK: Neuropathology and Applied Neurobiology: Wiley-Blackwell.
  • Jellinger K, Kienzl E, Janetzky B, Attems J, Preddie E, Bergmann J, Rattay F. Expression of a piggy-back-gene determines Alzheimer disease pathology?. In: 18th World Congress of Neurology. 2005, Sydney, Australia: Journal of the Neurological Sciences: Elsevier BV.
  • Attems J, Lintner F, Jellinger KA. Relations between cerebral amyloid angiopathy and Alzheimer's disease pathology. In: 9th International Conference on Alzheimers Disease and Related Disorders. 2004, Philadelphia, Pennsylvania, USA: Neurobiology of Aging: Elsevier.
  • Hudelist G, Koestler W, Attems J, Czerwenka K, Mueller R, Manavi M, Steger G, Kubista E, Zielinski CJ, Singer CF. Active Her-2/neu signal transduction in breast cancer - relevance of a ligand-independent activation mechanism and impact an the efficacy of trastuzumab-based treatment. In: 40th Annual Meeting of the American Society of Clinical Oncology. 2004, New Orleans, Louisiana, USA: Journal of Clinical Oncology: American Society of Clinical Oncology.
  • Kienzl E, Attems J, Bergmann J, Janetzky B, Dal-Bianco P, Steindl F, Rattay F, Preddie E, Jellinger K. A proteomic and immunhistochemical approach to the study of Alzheimer disease. In: 9th International Conference on Alzheimers Disease and Related Disorders. 2004, Philadelphia, Pennsylvania, USA: Neurobiology of Aging: Elsevier.

• Editorials

  • Attems J. The first year. Acta Neuropathologica 2019.
  • Attems J. The multi-morbid old brain. Acta Neuropathologica 2017, 134(2), 169-170.
  • Lassmann H, Bancher C, Attems J, Paulus W. In honor of the 80th birthday of Kurt Jellinger: a living legend in neuropathology. Acta Neuropathologica 2011, 121(5), 565-568.

• Letters

  • McAleese KE, Walker L, Colloby SJ, Taylor J-P, Thomas AJ, DeCarli C, Attems J. Cortical tau pathology: A major player in fibre-specific white matter reductions in Alzheimer's disease?. Brain 2018, 141(6), e44.
  • Skrobot OA, Attems J, Esiri M, Hortobagyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S. Reply: Atherosclerosis and vascular cognitive impairment neuropathological guideline. Brain 2017, 140(2), e13-e13.
  • Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Author response: Autopsy validation of 123 I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 2017, 89(7), 751-751.
  • Robinson AC, Palmer L, Love S, Hamard M, Esiri M, Ansorge O, Lett D, Attems J, Morris C, Troakes C, Selvackadunco S, King A, Al-Sarraj S, Mann DMA. Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK. Acta Neuropathologica 2016, 132(5), 753-755.
  • Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, Montine TJ, Nelson PT, Schmitt F, Schneider JA, Serrano-Pozo A, Thal DR, Toledo JB, Trojanowski JQ, Troncoso JC, Vonsattel JP, Wisniewski T. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica 2015, 129(5), 757-762.
  • Jellinger KA, Attems J. Rapidly progressing diffuse Lewy body disease. Movement Disorders 2011, 26(14), 2584-2585.
  • Watzka SB, Kostler WJ, Attems J. Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: still to be established: Author Reply. European Journal of Cardio-Thoracic Surgery 2011, 39(3), 428.
  • Watzka SB, Kostler WJ, Attems J. Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: still to be established [reply]. European Journal of Cardio-Thoracic Surgery 2011, 39(3), 428-428.

• Notes

  • Attems J, Jellinger K. Proteomics for synaptic markers of cognitive decline in neurodegenerative diseases. Brain 2018, 141(2), 329-331.
  • McKeith IG. Author response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2018, 90(6), 301-301.
  • Attems J. Alzheimer's disease pathology in synucleinopathies. The Lancet Neurology 2017, 16(1), 1234-.
  • Zhang M-D, Barde S, Szodorai E, Josephson A, Mitsios N, Watanabe M, Attems J, Lubec G, Kovacs GG, Uhlen M, Mulder J, Harkany T, Hokfelt T. Erratum to: Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord (Brain Struct Funct, 10.1007/s00429-016-1191-3). Brain Structure and Function 2016, 221(7), 3843-3843.
  • Howlett DR, Attems J, Francis PT. Spreading pathologies precede cognitive decline in Alzheimer's disease. Biological Psychiatry 2015, 77(8), 678-679.
  • Attems J, Lintner F, Jellinger KA. [correction] Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology (vol 107, pg 283, 2004). Acta Neuropathologica 2004, 107(5), 479-480.

• Reviews

  • Walker L, Attems J. Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms. Journal of Parkinson's Disease 2024, 14(1), 35-52.
  • Outeiro TF, Alcalay RN, Antonini A, Attems J, Bonifati V, Cardoso F, Chesselet M-F, Hardy J, Madeo G, McKeith I, Mollenhauer B, Moore DJ, Rascol O, Schlossmacher MG, Soreq H, Stefanis L, Ferreira JJ. Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease". Movement Disorders 2023, 38(7), 1127-1142.
  • Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, McKeith I. Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders. Acta Neuropathologica 2021, 141, 511-526.
  • Erskine D, Attems J. Insights into Lewy body disease from rare neurometabolic disorders. Journal of Neural Transmission 2021, 128, 1567-1575.
  • Walker L, Stefanis L, Attems J. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directions. Journal of Neurochemistry 2019, 150(5), 467-474.
  • McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017, 89(1), 88-100.
  • Attems J, Walker L, Jellinger KA. Olfaction and Aging: A Mini-Review. Gerontology 2015, 61(6), 485-490.
  • Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. Journal of Neural Transmission 2015, 122(4), 505-521.
  • Thal DR, Attems J, Ewers M. Spreading of amyloid, tau, and microvascular pathology in alzheimer's disease: Findings from neuropathological and neuroimaging studies. Journal of Alzheimer's Disease 2014, 42(s4), S421-S429.
  • Attems J, Neltner JH, Nelson PT. Quantitative neuropathological assessment to investigate cerebral multi-morbidity. Alzheimer's Research and Therapy 2014, 6, 85.
  • Attems J, Walker L, Jellinger KA. Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathologica 2014, 127(4), 459-475.
  • Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. Journal of the Neurological Sciences 2007, 257(1-2), 80-87.